Singal AK, Mathurin P. Diagnosis and treatment of alcohol-associated liver disease: a review. JAMA. 2021;326:165–76.

CAS  Article  Google Scholar 

Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018;15:753–64.

CAS  Article  Google Scholar 

Kim TY, Kim DJ. Acute-on-chronic liver failure. Clin Mol Hepatol. 2013;19:349–59.

Article  Google Scholar 

Flamm SL, Yang YX, Singh S, et al. American Gastroenterological Association Institute guidelines for the diagnosis and management of acute liver failure. Gastroenterology. 2017;152:644–7.

Article  Google Scholar 

Singal AK, Louvet A, Shah VH, Kamath PS. Grand rounds: alcoholic hepatitis. J Hepatol. 2018;69:534–43.

Article  Google Scholar 

Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353–90.

Article  Google Scholar 

Tufoni M, Baldassarre M, Zaccherini G, et al. Hemodynamic and systemic effects of albumin in patients with advanced liver disease. Curr Hepatol Rep. 2020:1–12.

Bernardi M, Angeli P, Claria J, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69:1127–38.

CAS  Article  Google Scholar 

Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60:255–60.

CAS  Article  Google Scholar 

Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978;75:193–9.

CAS  Article  Google Scholar 

Chen F, Shi Y, Liu X, et al. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failure. Expert Rev Gastroenterol Hepatol. 2019;13:1129–35.

CAS  Article  Google Scholar 

Zhe-Bin W, Ke W, Mo ZS, et al. Early, short-term, low-dose glucocorticoid therapy effectively blocks progression of severe acute exacerbation of chronic hepatitis B to liver failure. Clin Res Hepatol Gastroenterol. 2020;101505.

Kamath PS, Therneau T, Shah VH. MELDing the Lille score to more accurately predict mortality in alcoholic hepatitis. Gastroenterology. 2015;149:281–3.

Article  Google Scholar 

Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–54.

CAS  Article  Google Scholar 

Singal AK, Bataller R, Ahn J, et al. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113:175–94.

Article  Google Scholar 

Crabb DW, Im GY, Szabo G, et al. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–33.

Article  Google Scholar 

Xue R, Meng Q. The management of glucocorticoid therapy in liver failure. Front Immunol. 2019;10:2490.

CAS  Article  Google Scholar 

Deng JW, Yang Q, Cai XP, et al. Early use of dexamethasone increases Nr4a1 in Kupffer cells ameliorating acute liver failure in mice in a glucocorticoid receptor-dependent manner. J Zhejiang Univ Sci B. 2020;21:727–39.

CAS  Article  Google Scholar 

Caraceni P, Riggio O, Angeli P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391:2417–29.

CAS  Article  Google Scholar 

Fernandez J, Claria J, Amoros A, et al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology. 2019;157:149–62.

CAS  Article  Google Scholar